Motiza Itopride for Stomach Upset & Other Gastrointestinal Problems Part 1
Introduction
Itopride Hydrochloride under the brand name Motiza is a prokinetic (energizing) benzamide derivative, not dissimilar to metoclopramide or domperidone. These medications stamp down dopamine (a monoamine neurochemical detected in the brain and facilitates standard working of central nervous system) and boast a gastrokinetic impact. Motiza (Itopride) is primarily used for the treatment of functional dyspepsia or stomach upset and other gastrointestinal (GI) ailments. Itopride Hydrochloride is marketed by J.B. Chemicals & Pharmaceuticals.
Drug Approval
Itopride is not presently given approval by the US Food and Drug Administration (FDA) to be used in the United States. Similar case is also prevailing in the United Kingdom. This may explicate the evident dearth of prescribing information accessible in English when compared with other similar classes of medication.
Mechanism of Action
Motiza (Itopride) works by increasing acetylcholine absorptions with the inhibition of dopamine D2 receptors and acetylcholinesterase. Greater acetylcholine level steps up gastrointestinal vermiculation, augments the lower esophageal sphincter muscle pressure, stimulates stomachal movement, speeds up stomachal evacuation, and ameliorates gastro-duodenal synchronization.
Drug Indications of Itopride Hydrochloride
In a typical manner, Motiza (Itopride) is indicated in the medical intervention of gastrointestinal (GI)